Volitionrx Ltd (VNRX)

Currency in USD
0.171
+0.011(+6.87%)
Closed·
0.169-0.002(-1.17%)
·
VNRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.1570.174
52 wk Range
0.1500.940
Key Statistics
Prev. Close
0.171
Open
0.16
Day's Range
0.157-0.174
52 wk Range
0.15-0.94
Volume
3.28M
Average Vol. (3m)
11.32M
1-Year Change
-65.8%
Book Value / Share
-0.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VNRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.960
Upside
+1,046.20%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Volitionrx Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.

Volitionrx Ltd Earnings Call Summary for Q4/2025

  • VolitionRx posted Q4 2025 EPS of -$0.04, beating estimates by 14.35%, but revenue of $420K missed forecasts by 41.51%, triggering a 5.54% stock decline.
  • Company achieved 133% year-over-year revenue growth in Q4 2025 while reducing operating expenses by 17% as it transitions from R&D to commercialization.
  • Cash position stands at $1.1 million at year-end 2025, raising liquidity concerns amid unpredictable early-stage commercialization revenue patterns.
  • Management declined to provide 2026 revenue guidance but projects 25%-30% operating expense reduction and expects solid year-over-year growth.
  • Stock has plummeted 67.5% over six months to $0.191, with market cap at $26.13 million, reflecting investor concerns over revenue volatility.
Last Updated: 04/01/2026, 09:38 AM
Read Full Transcript

Compare VNRX to Peers and Sector

Metrics to compare
VNRX
Peers
Sector
Relationship
P/E Ratio
−1.2x−2.6x−0.5x
PEG Ratio
−0.04−0.300.00
Price / Book
−0.8x4.8x2.6x
Price / LTM Sales
15.7x8.1x3.2x
Upside (Analyst Target)
-46.4%45.7%
Fair Value Upside
Unlock−6.7%4.8%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.960
(+1,046.20% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy1.00+484.80%1.50MaintainApr 06, 2026
Benchmark
Hold---MaintainApr 02, 2026
Maxim Group
Hold---DowngradeDec 03, 2025
Freedom Capital Markets
Buy1.00+484.80%2.00MaintainNov 21, 2025
H.C. Wainwright
Buy1.50+777.19%2.50MaintainNov 18, 2025

Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
-0.05 / -0.05
Revenue / Forecast
420K / 718.08K
EPS Revisions
Last 90 days

VNRX Income Statement

People Also Watch

1.140
AIXI
+5.56%
12.120
UGRO
-4.72%
0.5087
TPET
-0.25%
1.36
UCAR
-9.93%
2.890
MOBX
+9.89%

FAQ

What Is the Volitionrx Ltd (VNRX) Stock Price Today?

The Volitionrx Ltd stock price today is 0.171 USD.

What Stock Exchange Does Volitionrx Ltd Trade On?

Volitionrx Ltd is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Volitionrx Ltd?

The stock symbol for Volitionrx Ltd is "VNRX."

What Is the Volitionrx Ltd Market Cap?

As of today, Volitionrx Ltd market cap is 27.100M USD.

What Is Volitionrx Ltd's Earnings Per Share (TTM)?

The Volitionrx Ltd EPS (TTM) is -0.219.

When Is the Next Volitionrx Ltd Earnings Date?

Volitionrx Ltd will release its next earnings report on May 13, 2026.

From a Technical Analysis Perspective, Is VNRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Volitionrx Ltd Stock Split?

Volitionrx Ltd has split 0 times.

How Many Employees Does Volitionrx Ltd Have?

Volitionrx Ltd has 75 employees.

What is the current trading status of Volitionrx Ltd (VNRX)?

As of Apr 16, 2026, Volitionrx Ltd (VNRX) is trading at a price of 0.171 USD, with a previous close of 0.171 USD. The stock has fluctuated within a day range of 0.157 USD to 0.174 USD, while its 52-week range spans from 0.150 USD to 0.940 USD.

What Is Volitionrx Ltd (VNRX) Price Target According to Analysts?

The average 12-month price target for Volitionrx Ltd is 1.960 USD, with a high estimate of 3 USD and a low estimate of 1 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,046.20% Upside potential.

What Is the VNRX After Hours Price?

VNRX's last after hours stock price is 0.169 USD, the stock has decreased by -0.002, or -1.170%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.